SubsidieMeesters logoSubsidieMeesters
ProjectenRegelingenAnalyses

OMI AI ECG Model - application for more accurate heart attack diagnosis

The OMI AI ECG Model is an AI mobile app that enhances OMI diagnosis from ECGs, improving sensitivity and speed, ultimately transforming heart attack management and saving lives.

Subsidie
€ 2.499.999
2024

Projectdetails

Introduction

Globally, 50M patients with chest pain present to emergency departments each year. In these patients, a 12-lead electrocardiogram (ECG) serves as a swift and readily available diagnostic test for identifying acute obstructive heart attacks (OMI), a life-threatening condition that requires prompt transfer to a cardiac catheterization laboratory.

OMI AI ECG Model

The OMI AI ECG Model is an AI-powered mobile application that can process any ECG and diagnose OMI faster and more precisely than current state-of-the-art criteria, according to which 50% of OMI cases are missed or delayed in treatment.

Technology Overview

This technology combines:

  • A patented ECG digitization system that converts any paper-form or screen-based images of ECGs into standardized digital waveforms.
  • An AI algorithm trained by physician experts with 50+ years of experience in OMI diagnosis from ECG who established the OMI paradigm.

Applicability

It is immediately applicable, doesn't require additional hardware, and works with any healthcare infrastructure.

Validation and Impact

In a large international validation of over 2,000 patients, it has proven to be twice as sensitive as the current standard of care in diagnosing OMI and can detect it 2.9 hours faster.

Benefits

Due to more accurate and faster diagnosis, this solution will cause a paradigm shift in heart attack patient management, saving millions of lives and decreasing the economic burden of cardiovascular disease.

Financiële details & Tijdlijn

Financiële details

Subsidiebedrag€ 2.499.999
Totale projectbegroting€ 4.495.966

Tijdlijn

Startdatum1-1-2024
Einddatum30-6-2026
Subsidiejaar2024

Partners & Locaties

Projectpartners

  • POWERFUL MEDICAL SROpenvoerder

Land(en)

Slovakia

Inhoudsopgave

EIC Accelerator

EU-subsidieprogramma voor mkb en start-ups met grants tot €2,5 mln en equity-investeringen tot €15 mln voor baanbrekende innovaties.

Bekijk regeling

Vergelijkbare projecten binnen EIC Accelerator

ProjectRegelingBedragJaarActie

AI-based clinical software for fully automated Cardiac Magnetic Resonance reporting

AI4MedImaging is developing AI4CMR.Plus, a revolutionary software for automated cardiac assessment via CMR, aiming for a 2025 launch to enhance CVD diagnosis and improve patient outcomes.

EIC Accelerator€ 1.753.842
2022
Details

Acorai Heart Monitor - Non-invasive multi-sensor device for heart failure monitoring

The Acorai Heart Monitor is a non-invasive device using machine learning to estimate cardiac pressure in heart failure patients, aiming to improve treatment outcomes and reduce hospitalizations.

EIC Accelerator€ 2.299.633
2023
Details

WILLEM: AI to Reduce Cardiovascular Diseases

WILLEM is an automated cloud platform that analyzes ECGs to diagnose arrhythmias and predict cardiovascular diseases, enhancing clinical workflows with AI-driven insights.

EIC Accelerator€ 2.500.000
2022
Details

Advanced Remote Continuous patient Health mANaGemEnt SoLution

Checkpointcardio aims to revolutionize patient monitoring by establishing a 24/7 remote observation center using AI and wearables to enhance care for critically ill and chronic disease patients.

EIC Accelerator€ 2.436.000
2023
Details

Development and clinical evaluation of an end-to-end Heart Failure management solution powered by predictive AI

Implicity is developing an AI-driven platform to predict heart failure events using cardiac device data, enhancing patient care and reducing hospitalizations through tailored insights and management tools.

EIC Accelerator€ 2.488.359
2025
Details
EIC Accelerator

AI-based clinical software for fully automated Cardiac Magnetic Resonance reporting

AI4MedImaging is developing AI4CMR.Plus, a revolutionary software for automated cardiac assessment via CMR, aiming for a 2025 launch to enhance CVD diagnosis and improve patient outcomes.

EIC Accelerator
€ 1.753.842
2022
Details
EIC Accelerator

Acorai Heart Monitor - Non-invasive multi-sensor device for heart failure monitoring

The Acorai Heart Monitor is a non-invasive device using machine learning to estimate cardiac pressure in heart failure patients, aiming to improve treatment outcomes and reduce hospitalizations.

EIC Accelerator
€ 2.299.633
2023
Details
EIC Accelerator

WILLEM: AI to Reduce Cardiovascular Diseases

WILLEM is an automated cloud platform that analyzes ECGs to diagnose arrhythmias and predict cardiovascular diseases, enhancing clinical workflows with AI-driven insights.

EIC Accelerator
€ 2.500.000
2022
Details
EIC Accelerator

Advanced Remote Continuous patient Health mANaGemEnt SoLution

Checkpointcardio aims to revolutionize patient monitoring by establishing a 24/7 remote observation center using AI and wearables to enhance care for critically ill and chronic disease patients.

EIC Accelerator
€ 2.436.000
2023
Details
EIC Accelerator

Development and clinical evaluation of an end-to-end Heart Failure management solution powered by predictive AI

Implicity is developing an AI-driven platform to predict heart failure events using cardiac device data, enhancing patient care and reducing hospitalizations through tailored insights and management tools.

EIC Accelerator
€ 2.488.359
2025
Details

Vergelijkbare projecten uit andere regelingen

ProjectRegelingBedragJaarActie

Schaalbare AI voor patiënten met pijn op de borst

Het project ontwikkelt een AI-algoritme dat cardiologen ondersteunt bij het aanvragen van CT-scans voor patiënten met pijn op de borst.

1.1 - Het ve...€ 795.688
2024
Details

ECG@HOME

Het project ontwikkelt een gebruiksvriendelijk ECG-apparaat voor thuisdiagnose van hartziekten zonder cardioloog.

1.1 - Het ve...€ 149.011
2023
Details

Oog voor het Hart: de miniECG

Het project ontwikkelt een miniECG voor huisartsen om snel en goedkoop hartdiagnoses te stellen, waardoor patiënten beter geholpen worden en de druk op specialisten vermindert.

Mkb-innovati...€ 340.060
2021
Details

Optimize risk prediction after myocardial infarction through artificial intelligence and multidimensional evaluation

This project aims to enhance myocardial infarction risk prediction by integrating data from wearable devices, biomarkers, and AI to identify novel risk factors for improved clinical decision-making.

ERC Starting...€ 1.405.894
2024
Details

A Multi-Omics Approach for Novel Drug Targets, Biomarkers and Risk Algorithms for Myocardial Infarction

TargetMI aims to rapidly discover novel drug targets and biomarkers for myocardial infarction using a high-throughput multi-omic approach on 1000 samples, enhancing clinical risk prediction and translation.

EIC Pathfinder€ 3.999.840
2023
Details
1.1 - Het ve...

Schaalbare AI voor patiënten met pijn op de borst

Het project ontwikkelt een AI-algoritme dat cardiologen ondersteunt bij het aanvragen van CT-scans voor patiënten met pijn op de borst.

1.1 - Het versterken van de onderzoeks- en innovatiecapaciteit en de invoering van geavanceerde technologieën
€ 795.688
2024
Details
1.1 - Het ve...

ECG@HOME

Het project ontwikkelt een gebruiksvriendelijk ECG-apparaat voor thuisdiagnose van hartziekten zonder cardioloog.

1.1 - Het versterken van de onderzoeks- en innovatiecapaciteit en de invoering van geavanceerde technologieën
€ 149.011
2023
Details
Mkb-innovati...

Oog voor het Hart: de miniECG

Het project ontwikkelt een miniECG voor huisartsen om snel en goedkoop hartdiagnoses te stellen, waardoor patiënten beter geholpen worden en de druk op specialisten vermindert.

Mkb-innovatiestimulering Topsectoren R&D Samenwerking
€ 340.060
2021
Details
ERC Starting...

Optimize risk prediction after myocardial infarction through artificial intelligence and multidimensional evaluation

This project aims to enhance myocardial infarction risk prediction by integrating data from wearable devices, biomarkers, and AI to identify novel risk factors for improved clinical decision-making.

ERC Starting Grant
€ 1.405.894
2024
Details
EIC Pathfinder

A Multi-Omics Approach for Novel Drug Targets, Biomarkers and Risk Algorithms for Myocardial Infarction

TargetMI aims to rapidly discover novel drug targets and biomarkers for myocardial infarction using a high-throughput multi-omic approach on 1000 samples, enhancing clinical risk prediction and translation.

EIC Pathfinder
€ 3.999.840
2023
Details

SubsidieMeesters logoSubsidieMeesters

Vind en verken subsidieprojecten in Nederland en Europa.

Links

  • Projecten
  • Regelingen
  • Analyses

Suggesties

Heb je ideeën voor nieuwe features of verbeteringen?

Deel je suggestie
© 2025 SubsidieMeesters. Alle rechten voorbehouden.